Skip to content

Systematic review and meta-analysis shows equivalence of 3TC and FTC

Once-daily raltegravir effective as maintenance therapy

Persisently detectable viral load at any level increases risk of HIV treatment failure

Kidney problems linked to tenofovir use, improve with switch to abacavir

Ameet Dravid at IAS 2013. Photo by Liz Highleyman, hivandhepatitis.com.

Study supports WHO recommendations for second-line HIV therapy in resource-limited countries

Nicholas Paton of the Europe-Africa Research Network for Evaluation of Second-line Therapy (EARNEST). Photo by Jan Brittenson, hivandhepatitis.com.

AZT associated with poorer immunological recovery in people taking first-line HIV treatment in southern Africa

London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

Second-line NRTI-sparing regimen proves equally effective for resource-limited settings